Testosterone Nanoemulsion Prevents Prostate Cancer: PC-3 and LNCaP Cell Viability In Vitro
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25147729 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Marco Antonio Botelho und 1 weiteren Autor:innen. Beteiligte Einrichtung: Ceara Institute of Science and Technology (IFCE), Sobral 62042-030, Brazil. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Testosterone, Emulsions, Cell Survival. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Counsel of Technological and Scientific Development [CNPq].
Abstract (Originalsprache)
For many years, it has been speculated that elevated testosterone levels may be critically involved in the genesis and proliferation of prostate cancer.
Methods
The effect of testosterone on the metabolic activity of hormone-independent [PC-3] and hormone-dependent [LNCAP] cancer cells was investigated in vitro. Additionally, the impact of testosterone nanoemulsion [nanocare®] on cell viability was accessed by flow cytometry.
Results
Despite the dependency of the normal prostate and of most prostatic cancers upon androgens, the obtained results indicate that, contrary to prevailing opinion, the supplementation of testosterone with higher doses in nanoemulsion was able to lower the metabolic activity and viability of prostate cancer cells.
Conclusions
We conclude that the growth of hormone-independent and hormone-dependent prostate cancer cells was reduced by the exposure of a nanoemulsion of bioidentical testostosterone in vitro. To the best of our knowledge, this is the first time that the potential effect of a testosterone nanoemulsion on the metabolic activity of prostate cancer cells has been shown. Such tests suggest that the growth of hormone-independent and hormone-dependent prostate cancer cells was reduced by the administration of bioidentical testostosterone, and this might be an interesting strategy for prostate cancer treatment in diagnosed patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Ceara Institute of Science and Technology (IFCE), Sobral 62042-030, Brazil.
- Laboratoire Matière et Systèmes Complexes, UMR 7057, CNRS and Université Paris Diderot, 10 rue Alice Domon et Léonie Duquet, 75205 Paris cedex 13, France.
ORCID-Profile: Marco Antonio Botelho
Förderung
- National Counsel of Technological and Scientific Development [CNPq]
Zitieren
APA
Botelho, M. A., & Queiroz, D. B. (2024). Testosterone Nanoemulsion Prevents Prostate Cancer: PC-3 and LNCaP Cell Viability In Vitro. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25147729
Vancouver
Botelho MA, Queiroz DB. Testosterone Nanoemulsion Prevents Prostate Cancer: PC-3 and LNCaP Cell Viability In Vitro. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25147729
BibTeX
@article{Botelho2024,
author = {Botelho, Marco Antonio and Queiroz, Dinalva Brito},
title = {Testosterone Nanoemulsion Prevents Prostate Cancer: PC-3 and LNCaP Cell Viability In Vitro},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25147729}
}
EUVIMED